Comparative genomic hybridization in glioma: a meta-analysis of 509 cases

被引:70
作者
Koschny, R
Koschny, T
Froster, UG
Krupp, W
Zuber, MA
机构
[1] Univ Leipzig, Inst Human Genet, D-04103 Leipzig, Germany
[2] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany
[3] Univ Leipzig, Clin Neurosurg, D-04103 Leipzig, Germany
关键词
D O I
10.1016/S0165-4608(01)00650-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Much data about genetic imbalances in tumors have been accumulated by comparative genomic hybridization (CGH). In order to distinguish between significantly and coincidentally involved regions in glioma by means of a meta-analysis, we summarized and analyzed the CGH results of 509 cases published in 26 reports between 1992 and 2001. The expansion of all aberrations to the 850-band level impressively visualized distinct patterns in astrocytoma, oligodendroglioma, and ependymoma as well as loci of frequent aberrations. For example, in astrocytoma the frequency of gains culminated at 7p12, 8q24.1, and 12q13similar toq15 (the loci of EGF-R, C-MYC and CDK4, respectively) and losses at 9p21 (the locus of p15 and p16) and 10q23.3 where PTEN resides. Most chromosomes were variably prone to copy number changes at different scales of aberrations. At the whole chromosome level the analysis showed +7, -10 in astrocytoma and +9, +18 in ependymoma, but +20q, -9p in astrocytoma and +1q, -22q in ependymoma at the p-q arm level. Furthermore, we could confirm the correlation between the average number of copy alterations per patient (average number of copy alterations [ANCA] index) and malignancy for astrocytoma in a refined graduation as well as for oligodendroglioma. As a new parameter, the average number of affected GTG-bands per patient (average number of affected GTG bands [ANAG] index) showed an even more striking correlation with the World Health Organization grade for gains and losses. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:147 / 159
页数:13
相关论文
共 82 条
[1]   GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas [J].
Almeida, A ;
Zhu, XX ;
Vogt, N ;
Tyagi, R ;
Muleris, M ;
Dutrillaux, AM ;
Dutrillaux, B ;
Ross, D ;
Malfoy, B ;
Hanash, S .
ONCOGENE, 1998, 16 (23) :2997-3002
[2]   APPLICATION OF A SIMPLIFIED COMPARATIVE GENOMIC HYBRIDIZATION TECHNIQUE TO SCREEN FOR GENE AMPLIFICATION IN PEDIATRIC SOLID TUMORS [J].
BAYANI, J ;
THORNER, P ;
ZIELENSKA, M ;
PANDITA, A ;
BEATTY, B ;
SQUIRE, JA .
PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1995, 15 (06) :831-844
[3]   Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization [J].
Bigner, SH ;
Matthews, MR ;
Rasheed, BKA ;
Wiltshire, RN ;
Friedman, HS ;
Friedman, AH ;
Stenzel, TT ;
Dawes, DM ;
McLendon, RE ;
Bigner, DD .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (02) :375-386
[4]   MOLECULAR ANALYSIS OF GENETIC CHANGES IN EPENDYMOMAS [J].
BIJLSMA, EK ;
VOESTEN, AMJ ;
BIJLEVELD, EH ;
TROOST, D ;
WESTERVELD, A ;
MEREL, P ;
THOMAS, G ;
HULSEBOS, TJM .
GENES CHROMOSOMES & CANCER, 1995, 13 (04) :272-277
[5]   The glial and mesenchymal elements of gliosarcomas share similar genetic alterations [J].
Boerman, RH ;
Anderl, K ;
Herath, J ;
Borell, T ;
Johnson, N ;
SchaefferKlein, J ;
Kirchhof, A ;
Raap, AK ;
Scheithauer, BW ;
Jenkins, RB .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (09) :973-981
[6]   THE P53 GENE AND ITS ROLE IN HUMAN BRAIN-TUMORS [J].
BOGLER, O ;
HUANG, HJS ;
KLEIHUES, P ;
CAVENEE, WK .
GLIA, 1995, 15 (03) :308-327
[7]  
Boström J, 1998, CANCER RES, V58, P29
[8]  
Broberg K, 2001, GENE CHROMOSOME CANC, V30, P310, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1096>3.3.CO
[9]  
2-3
[10]   Comparative genomic hybridization reveals recurrent enhancements on chromosome 20 and in one case combined amplification sites on 15q24q26 and 20p11p12 in glioblastomas [J].
Brunner, C ;
Jung, V ;
Henn, W ;
Zang, KD ;
Urbschat, S .
CANCER GENETICS AND CYTOGENETICS, 2000, 121 (02) :124-127